Clinical Trial Update: Study of IV Human Plasma-derived C1 Esterase Inhibitor Concentrate in Patients With Congenital C1-INH Deficiency for Treatment and Pre-procedure Preventing of Acute Hereditary Angioedema Attacks [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating IV human plasma-derived C1 esterase inhibitor concentrate for treatment and pre-procedure prevention of acute hereditary angio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hereditary Angioedema

Drugs mentioned

• C1 esterase inhibitor concentrate (human plasma-derived) (C1-esterase inhibitor concentrate)

Snippet

Sponsor: Octapharma | Conditions: Acute Hereditary Angio Edema | Phase 3 | Status: RECRUITING